SEC Form 4 · accession 0001161697-17-000010
CATALYST PHARMACEUTICALS, INC. · CPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Donald A Denkhaus
Director
Period of report
Jan 3, 2017
Accepted (ET)
Jan 5, 2017 · 5:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001369568
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options to purchase common stock | $1.13 | Jan 3, 2017 | A | 30,000 | A | Jan 3, 2017 | Jan 3, 2024 | Common Stock | 30,000 | 170,000 | D |
| Options to purchase common stock | $1.13 | Jan 3, 2017 | A | 30,000 | A | Jan 3, 2018 | Jan 3, 2024 | Common Stock | 30,000 | 200,000 | D |